Eleven Biotherapeutics reported $-807000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US $ 1476M 423M
Bayer BAYN:GR € 3291M 2130M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Corcept Therapeutics CORT:US $ 22.8M 9.26M
Eleven Biotherapeutics EBIO:US $ -0.81M 9.75M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Intrexon XON:US $ -19.25M 5.78M
Merk MRK:US $ 4310M 552M
Pfizer PFE:US $ 7863M 4470M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.8M
Ziopharm Oncology ZIOP:US $ -9.79M 2.01M